Wirebaugh S R, Geraets D R
College of Pharmacy, University of Iowa, Iowa City 52242.
DICP. 1990 Jan;24(1):22-5. doi: 10.1177/106002809002400104.
Patients diagnosed with incurable or fatal diseases may seek alternatives to standard medical therapy and spend significant amounts of money for these therapies. One alternative medical therapy, chelation therapy with edetic acid (EDTA), has gained considerable popularity for the alleged treatment of atherosclerotic vascular disease; however, its efficacy for this indication remains unproven and its use is controversial. We present a case in which chelation therapy was unsuccessful in treating coronary atherosclerosis and review reports that substantiate a lack of efficacy using chelation therapy in the treatment of coronary atherosclerosis. Treatment of atherosclerotic-related diseases using chelation therapy should be discouraged by health professionals. Patients should be counseled regarding the risk of improper diagnosis and treatment of their disease.
被诊断患有不治之症或绝症的患者可能会寻求标准医学疗法之外的其他疗法,并为这些疗法花费大量金钱。一种替代医学疗法,即乙二胺四乙酸(EDTA)螯合疗法,因据称可治疗动脉粥样硬化性血管疾病而颇受欢迎;然而,其对该适应症的疗效尚未得到证实,其使用也存在争议。我们报告一例螯合疗法治疗冠状动脉粥样硬化失败的病例,并回顾那些证实螯合疗法在治疗冠状动脉粥样硬化方面缺乏疗效的报告。健康专业人员应不鼓励使用螯合疗法治疗与动脉粥样硬化相关的疾病。应向患者提供有关其疾病诊断和治疗不当风险的咨询。